UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 261

Sortiert nach

Inhibition of cGAS DNA Sensing by a Herpesvirus Virion Protein

Cell host & microbe, 2015-09, Vol.18 (3), p.333-344

2015

Volltextzugriff (PDF)

Viral, immunologic, and clinical features of primary effusion lymphoma

Blood, 2019-04, Vol.133 (16), p.1753-1761

2019

Volltextzugriff (PDF)

Genomic changes in Kaposi Sarcoma-associated Herpesvirus and their clinical correlates

PLoS pathogens, 2022-11, Vol.18 (11), p.e1010524-e1010524

2022

Volltextzugriff (PDF)

Kaposi's sarcoma-associated herpesvirus T cell responses in HIV seronegative individuals from rural Uganda

Nature communications, 2021-12, Vol.12 (1), p.7323-9, Article 7323

2021

Volltextzugriff (PDF)

Signatures of oral microbiome in HIV-infected individuals with oral Kaposi's sarcoma and cell-associated KSHV DNA

PLoS pathogens, 2020-01, Vol.16 (1), p.e1008114

2020

Volltextzugriff (PDF)

Human and viral interleukin-6 and other cytokines in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease

Blood, 2013-12, Vol.122 (26), p.4189-4198

2013

Volltextzugriff (PDF)

KSHV infection of B cells primes protective T cell responses in humanized mice

Nature communications, 2024-06, Vol.15 (1), p.4841-13, Article 4841

2024

Volltextzugriff (PDF)

Immune cell phenotype and function patterns across the life course in individuals from rural Uganda

Frontiers in immunology, 2024-03, Vol.15, p.1356635-1356635

2024

Volltextzugriff (PDF)

Kaposi's Sarcoma-Associated Herpesvirus (KSHV) Induces the Oncogenic miR-17-92 Cluster and Down-Regulates TGF-β Signaling

PLoS pathogens, 2015-11, Vol.11 (11), p.e1005255

2015

Volltextzugriff (PDF)

Targeting HGF/c-MET induces cell cycle arrest, DNA damage, and apoptosis for primary effusion lymphoma

Blood, 2015-12, Vol.126 (26), p.2821-2831

2015

Volltextzugriff (PDF)

Comparison of Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus viral load in peripheral blood mononuclear cells and oral fluids of HIV-negative individuals aged 3-89 years from Uganda

Infectious agents and cancer, 2023-06, Vol.18 (1), p.38-38, Article 38

2023

Volltextzugriff (PDF)

Distinct genetic architectures and environmental factors associate with host response to the γ2-herpesvirus infections

Nature communications, 2020-07, Vol.11 (1), p.3849-13, Article 3849

2020

Volltextzugriff (PDF)

High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapy

Blood, 2011-06, Vol.117 (26), p.6977-6986

2011

Volltextzugriff (PDF)

ORF33 and ORF38 of Kaposi's Sarcoma-Associated Herpesvirus Interact and Are Required for Optimal Production of Infectious Progeny Viruses

Journal of virology, 2016-02, Vol.90 (4), p.1741-1756

2016

Volltextzugriff (PDF)

Phase II Study of Bevacizumab in Patients With HIV-Associated Kaposi's Sarcoma Receiving Antiretroviral Therapy

Journal of clinical oncology, 2012-05, Vol.30 (13), p.1476-1483

2012

Volltextzugriff (PDF)

Heterogeneity and breadth of host antibody response to KSHV infection demonstrated by systematic analysis of the KSHV proteome

PLoS pathogens, 2014-03, Vol.10 (3), p.e1004046

2014

Volltextzugriff (PDF)

Kaposi's sarcoma-associated herpesvirus seropositivity is associated with parasite infections in Ugandan fishing communities on Lake Victoria islands

PLoS neglected tropical diseases, 2019-10, Vol.13 (10), p.e0007776

2019

Volltextzugriff (PDF)

Trends in Kaposi's sarcoma‐associated Herpesvirus antibodies prior to the development of HIV‐associated Kaposi's sarcoma: A nested case‐control study

International journal of cancer, 2015-06, Vol.136 (12), p.2822-2830

2015

Volltextzugriff (PDF)

Oral Shedding of an Oncogenic Virus Alters the Oral Microbiome in HIV+ Patients

Frontiers in microbiology, 2022-04, Vol.13, p.882520

2022

Volltextzugriff (PDF)

Adaptive immune responses to Kaposi's sarcoma-associated herpesvirus

Current opinion in immunology, 2022-08, Vol.77, p.102230-102230, Article 102230

2022

Volltextzugriff (PDF)

Epstein-Barr virus (EBV) antibody changes over time in a general population cohort in rural Uganda, 1992-2008

Infectious agents and cancer, 2023-09, Vol.18 (1), p.55-55, Article 55

2023

Volltextzugriff (PDF)

KSHV (HHV8) vaccine: promises and potential pitfalls for a new anti-cancer vaccine

npj vaccines, 2022-09, Vol.7 (1), p.108-108, Article 108

2022

Volltextzugriff (PDF)

Sensitivity of the C-Terminal Nuclease Domain of Kaposi's Sarcoma-Associated Herpesvirus ORF29 to Two Classes of Active-Site Ligands

Antimicrobial agents and chemotherapy, 2018-10, Vol.62 (10)

2018

Volltextzugriff (PDF)

Hepatitis C and Risk of Lymphoma: Results of the European Multicenter Case-Control Study EPILYMPH

Gastroenterology (New York, N.Y. 1943), 2006-12, Vol.131 (6), p.1879-1886

2006

Volltextzugriff (PDF)

Risk Factors for Human Herpesvirus 8 Infection among Adults in the United States and Evidence for Sexual Transmission

The Journal of infectious diseases, 2007-07, Vol.196 (2), p.199-207

2007

Volltextzugriff (PDF)

1 – 25 von 261

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(253)
Mit Volltextzugriff
(244)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Inhibition of cGAS DNA Sensing by a Herpesvirus Virion Protein

Viral, immunologic, and clinical features of primary effusion lymphoma

Genomic changes in Kaposi Sarcoma-associated Herpesvirus and their clinical correlates

Kaposi's sarcoma-associated herpesvirus T cell responses in HIV seronegative individuals from rural Uganda

Signatures of oral microbiome in HIV-infected individuals with oral Kaposi's sarcoma and cell-associated KSHV DNA

Human and viral interleukin-6 and other cytokines in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease

KSHV infection of B cells primes protective T cell responses in humanized mice

Immune cell phenotype and function patterns across the life course in individuals from rural Uganda

Kaposi's Sarcoma-Associated Herpesvirus (KSHV) Induces the Oncogenic miR-17-92 Cluster and Down-Regulates TGF-β Signaling

Targeting HGF/c-MET induces cell cycle arrest, DNA damage, and apoptosis for primary effusion lymphoma

Comparison of Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus viral load in peripheral blood mononuclear cells and oral fluids of HIV-negative individuals aged 3-89 years from Uganda

Distinct genetic architectures and environmental factors associate with host response to the γ2-herpesvirus infections

High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapy

ORF33 and ORF38 of Kaposi's Sarcoma-Associated Herpesvirus Interact and Are Required for Optimal Production of Infectious Progeny Viruses

Phase II Study of Bevacizumab in Patients With HIV-Associated Kaposi's Sarcoma Receiving Antiretroviral Therapy

Heterogeneity and breadth of host antibody response to KSHV infection demonstrated by systematic analysis of the KSHV proteome

Kaposi's sarcoma-associated herpesvirus seropositivity is associated with parasite infections in Ugandan fishing communities on Lake Victoria islands

Trends in Kaposi's sarcoma‐associated Herpesvirus antibodies prior to the development of HIV‐associated Kaposi's sarcoma: A nested case‐control study

Oral Shedding of an Oncogenic Virus Alters the Oral Microbiome in HIV+ Patients

Adaptive immune responses to Kaposi's sarcoma-associated herpesvirus

Epstein-Barr virus (EBV) antibody changes over time in a general population cohort in rural Uganda, 1992-2008

KSHV (HHV8) vaccine: promises and potential pitfalls for a new anti-cancer vaccine

Sensitivity of the C-Terminal Nuclease Domain of Kaposi's Sarcoma-Associated Herpesvirus ORF29 to Two Classes of Active-Site Ligands

Hepatitis C and Risk of Lymphoma: Results of the European Multicenter Case-Control Study EPILYMPH

Risk Factors for Human Herpesvirus 8 Infection among Adults in the United States and Evidence for Sexual Transmission

Suchergebnisse filtern